Regenxbio (RGNX) Treasury Shares (2016 - 2025)

Regenxbio's Treasury Shares history runs 9 years deep, the most recent figure standing at $2.8 million for Q4 2025.

• In Q4 2025, Treasury Shares rose 39.57% year-over-year to $2.8 million; the TTM figure through Dec 2025 stood at $2.8 million (up 39.57% YoY), while the FY2025 annual figure was $2.8 million, up 39.57% from the prior year.
• Treasury Shares was $2.8 million for Q4 2025 at Regenxbio, down from $2.9 million in the prior quarter.
• In the past five years, Treasury Shares ranged from a high of $3.0 million in Q2 2025 to a low of $254000.0 in Q1 2021.
• Historically, Treasury Shares has averaged $1.4 million across 5 years, with a median of $1.4 million in 2023.
• The sharpest annual moves came in 2023 and 2024: Treasury Shares soared 200.42% in 2023, then increased 17.13% in 2024.
• A 5-year view of Treasury Shares shows it stood at $277000.0 in 2021, then soared by 121.3% to $613000.0 in 2022, then surged by 113.54% to $1.3 million in 2023, then surged by 56.0% to $2.0 million in 2024, then soared by 39.57% to $2.8 million in 2025.
• The last three Treasury Shares figures came in at $2.8 million (Q4 2025), $2.9 million (Q3 2025), and $3.0 million (Q2 2025), per Business Quant data.